Suppr超能文献

私人牙周病诊所中种植体的存活率和成功率:一项长达 10 年的回顾性研究。

Survival and success of implants in a private periodontal practice: a 10 year retrospective study.

机构信息

Section of Periodontology, Department of Conservative Dentistry, Clinic for Oral, Dental and Maxillofacial Diseases, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.

Private Practice, Niedernstrasse 16, 33602, Bielefeld, Germany.

出版信息

BMC Oral Health. 2020 Mar 30;20(1):92. doi: 10.1186/s12903-020-01064-z.

Abstract

BACKGROUND

To assess long-term results of implants (XiVE/Frialit-2 Synchro) in a private periodontal practice according to survival and success rates (biological and technical complications) and to detect possible influencing factors, retrospectively.

METHODS

Implant placement of at least one implant took place 10 years ±6 months before clinical and radiographic re-examination. Incidence of implant loss as main and incidence of mucositis/ peri-implantitis as secondary outcome were detected. Also, patient-related and implant-related influencing factors were determined by regression analyses.

RESULTS

100 patients (59.0% female) with 242 implants were included into analysis. Survival rate was 94.0% (XiVE: 97.7%; Frialit-2-Synchro: 66.7%). Mucositis was found in 77.6% of all patients, moderate/severe peri-implantitis in 16.3%. In logistic regression analyses statistically significant influencing factors for implant loss was implant type (p < 0.001), for mucositis a wider implant diameter (p = 0.0438) and a high modified Plaque Index (p = 0.0253), for peri-implantits number of implants per patient (p = 0.0075) and a wider implant diameter (p = 0.0079). Technical complications were found in 47 implants (19.4%).

CONCLUSIONS

XiVE implants showed a high survival rate over a 10-year follow-up, on the other hand Frialit-2 Synchro implants had worse survival rates. Success rates regarding biological complications are in line with other implant systems.

摘要

背景

本研究旨在回顾性评估一家私人牙周诊所中植入物(XiVE/Frialit-2 Synchro)的长期效果,包括存活率和成功率(生物和技术并发症),并检测可能的影响因素。

方法

在临床和影像学复查前 10 年±6 个月,至少植入 1 枚种植体。主要终点为种植体失败率,次要终点为种植体周围黏膜炎/炎的发生率。采用回归分析确定与患者和种植体相关的影响因素。

结果

共纳入 100 名患者(59.0%为女性),共植入 242 枚种植体。种植体 10 年存活率为 94.0%(XiVE:97.7%;Frialit-2-Synchro:66.7%)。所有患者中,77.6%发生种植体周围黏膜炎,16.3%发生中度/重度种植体周围炎。Logistic 回归分析显示,种植体类型(p<0.001)、种植体直径(p=0.0438)和改良菌斑指数(p=0.0253)是导致种植体失败的统计学显著影响因素;而种植体数量(p=0.0075)和种植体直径(p=0.0079)是导致种植体周围炎的统计学显著影响因素。共发现 47 枚种植体(19.4%)发生技术并发症。

结论

在 10 年的随访中,XiVE 种植体具有较高的存活率,而另一方面 Frialit-2 Synchro 种植体的存活率较低。在生物并发症方面,其成功率与其他种植体系统相当。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fcd/7106605/199c2fb2c6e2/12903_2020_1064_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验